TuHURA Biosciences HURA
NASDAQ HURA
$2.08 -0.01 (-0.24%)
As of: Oct 22, 2026 · 10:26 AM EDT

TuHURA Biosciences (HURA) Notes Payables (2025)

Updated

TuHURA Biosciences' Notes Payables came in at $493,386 for Q3 2025, up 13.7% from the prior quarter.

Analysis

TuHURA Biosciences (HURA) Notes Payables (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,166.70 Bn 1,135.28 Bn 19.71 Bn
2 Johnson & Johnson 633.99 Bn 552.52 Bn 17.26 Bn
3 AbbVie 502.96 Bn 476.07 Bn 12.70 Bn
4 Merck 377.09 Bn 331.47 Bn 12.21 Bn
5 Novartis Ag 303.78 Bn 267.77 Bn 11.24 Bn
6 Astrazeneca 266.66 Bn 240.35 Bn 12.86 Bn
7 Amgen 241.39 Bn 196.79 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 172.37 Bn 119.01 Bn 10.94 Bn
10 TuHURA Biosciences 132.20 Mn 118.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 493,386.00
Jun 30, 2025 434,000.00
API Access

TuHURA Biosciences Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=HURA&period=max&api_key=YOUR_API_KEY